The hepatoprotective effect of arbutin may depend on the regulation of bile acid synthetic enzymes and transporters by the activation of the FXR, suggesting that arbutin can be a potential drug to hepatic disease related to cholestasis. The gene discussed is NR1H4; the disease is liver disorder.